Reliance Life Sciences Private Limited

FDA inspection history in Navi Mumbai, India, 2026

1
Warning letter
1
Form 483

Every document, by year

  • Warning letter
  • Form 483

2026: one warning letter and one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2026One warning letter and one Form 483, at Navi Mumbai, India.

Cited most

Across all Reliance Life Sciences Private Limited observations on file

The complete Reliance Life Sciences Private Limited file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2026-08-18Warning letter Warning letter$99
2026-02-27483 Form 483$99

Investigators on these documents

Ashar P. Parikh (1)Eileen A. Liu (1)

FEI number 3009510975 · most recent document Aug 18, 2026

About Reliance Life Sciences Private Limited

How many FDA Form 483s has Reliance Life Sciences Private Limited received?

FDA Intel has 1 Form 483 on file for Reliance Life Sciences Private Limited; the most recent is dated Feb 27, 2026.

When was Reliance Life Sciences Private Limited last inspected by FDA?

The most recent FDA inspection document on file for Reliance Life Sciences Private Limited is a Form 483 dated Feb 27, 2026, for the site in Navi Mumbai, India.

What did FDA cite at Reliance Life Sciences Private Limited?

The regulations cited most in the observations on file for Reliance Life Sciences Private Limited are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.194 (Laboratory records), 1 time.

Has Reliance Life Sciences Private Limited received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Reliance Life Sciences Private Limited; the most recent is dated Aug 18, 2026.

Reliance Life Sciences Private Limited FDA 483s · FDA Intel